During the past decade, Landeskrankenhaus Bregenz conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Landeskrankenhaus Bregenz" #1 sponsor was "Bayer" with 3 trials, followed by "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 2 trials sponsored, "Shire" with 2 trials sponsored, "Aeglea Biotherapeutics" with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Landeskrankenhaus Bregenz" #1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Landeskrankenhaus Bregenz" are "Contraception" (2 trials), "Active Juvenile Psoriatic Arthritis" (1 trials), "Arginase I Deficiency" (1 trials), "Diffuse Large B-Cell Lymphoma (DLBCL)" (1 trials) and "Fabry Disease" (1 trials). Many other conditions were trialed in "Landeskrankenhaus Bregenz" in a lesser frequency.

Most popular intervention types in "Landeskrankenhaus Bregenz" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apremilast" (1 trials), "Baricitinib" (1 trials), "EV/DNG (Qlaira, BAY86-5027, SH T00658K)" (1 trials) and "FOLFIRI + Cetuximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Landeskrankenhaus Bregenz" are 9 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Landeskrankenhaus Bregenz". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Landeskrankenhaus Bregenz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Landeskrankenhaus Bregenz, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Landeskrankenhaus Bregenz has several departments that took part in Clinical trials: "Lhk Feldkirch; Interne Medizin Abt." - 5 trials, "LKH Feldkirch, Interne E" - 4 trials, "Landeskrankenhaus Rankweil; Interne E" - 3 trials